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 2 
Abstract 1 
In order to obtain an insight into genomic changes and associated evolution and 2 
adaptation of Infectious Pancreatic Necrosis Virus (IPNV) the complete coding 3 
genomes of 57 IPNV isolates collected from Scottish aquafarms from 1982-2014 4 
were sequenced and analysed. 5 
Phylogenetic analysis of the sequenced IPNV strains showed separate clustering of 6 
genogroups I, II, III and V. IPNV isolates with genetic reassortment of segment A/B of 7 
genogroup III/II were determined. About 59% of the IPNV isolates belonged to the 8 
persistent type and 32% to the low virulent type and only one highly pathogenic strain 9 
(1.79%) was identified. 10 
Codon adaptation index calculations indicated that the IPNV major capsid protein 11 
VP2 has adapted to its salmonid host. Underrepresentation of CpG dinucleotides in 12 
the IPNV genome to minimise detection by the innate immunity receptors, and 13 
observed positive selection in the virulence determination sites of VP2 embedded in 14 
the variable region of the main antigenic region, suggest an immune escape 15 
mechanism driving virulence evolution. 16 
The prevalence of mostly persistent genotypes together with the assumption of 17 
adaptation and immune escape indicates that IPNV is evolving with the host. 18 
 19 
  20 
 3 
Introduction 21 
RNA viruses are economically important pathogens of fish, and Infectious Pancreatic 22 
Necrosis Virus (IPNV) is of particular concern for the aquaculture industry, especially 23 
for farmed Atlantic salmon (Salmo salar, Linnaeus 1758) and Rainbow trout 24 
(Oncorhynchus mykiss, Walbaum 1792). This non-enveloped aquatic virus belongs 25 
to the family of Birnaviridae and has a bi-segmented double-stranded RNA genome 26 
of about 6 kilobases (kb). IPNV causes high mortality in fry and lower mortality in 27 
adult fish. Surviving fish can become carriers, and persistently infected fish can 28 
spread IPNV by vertical transmission via oocytes or by shedding infective material 29 
into water via faeces and urine, and by milt and seminal fluids leading to clinical 30 
outbreaks [1-9]. 31 
The genome is composed of two segments. Segment A contains a large open-32 
reading frame (ORF) encoding a polyprotein, composed of the major capsid viral 33 
protein 2 (VP2), the minor capsid protein VP3 and the Serine-Lysine protease VP4. A 34 
second ORF encodes the non-structural VP5 protein. Segment B contains only one 35 
ORF encoding the RNA-dependent RNA polymerase (RdRp/VP1) [10-14]. VP3 binds 36 
to RdRp and the dsRNA genome segments and seem to activate the RdRp [15, 16]. 37 
Furthermore, VP3 and VP4 inhibit IFNα (Interferon α) induction in salmon cells to 38 
block host immune response during infection [16]. VP5 is a non-structural arginine-39 
rich anti-apoptosis protein, which shares homologous domains with Bcl-2 (B-cell 40 
lymphoma 2) and shuts off the host’s apoptosis system by down regulation of Mcl-1 41 
(Induced myeloid leukaemia cell differentiation protein 1). As Mcl-1 induces cells to 42 
undergo apoptotic cell death but Bcl-2 blocks apoptosis, VP5, mimicking Bcl-2, 43 
enhances cell survival for the benefit of IPNV proliferation [17]. 44 
The major capsid protein VP2 is more variable in the coding region than RdRp, VP3 45 
and VP4 sequences and contains a variable domain in the central region between 46 
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the amino acid residues 183-335, which is an important antigenic site with two 47 
hypervariable regions at residues 239-257 and 271-284. Further studies revealed 48 
that mutations to threonine (T) from proline (P) at position 217 and Alanine (A) at 49 
position 221 are characteristic for virulent IPNV Sp isolates [18-20]. 50 
IPNV can have different virulence variants: virulent (T217, A221), persistent (P217, 51 
T221), avirulent (T217, T221) and low virulent (P217, A221) types. The virulent 52 
strains induce a high morbidity and mortality. Persistent strains induce a high 53 
morbidity (≤90%) and in general little to no mortality (less than 10%). Isolates with the 54 
residues T217, T221 induce a mortality of about 10%, isolates with the residues 55 
P217, A221 around 30%, and isolates with T217, A221 more than 60% [19-21]. 56 
IPNV is classified into 7 genogroups (I-VII) according to 10 known serotypes.  57 
Genogroup I contains the serotypes West Buxton, Buhl, Reno, VR299, Jasper-Dobos, 58 
Dry Mills and Jasper, genogroup II Abild, genogroup III Tellina, TV-1 and Canada1, 59 
genogroup IV Canada2 and Canada3, genogroup V Sparajub and N1, genogroup VI 60 
Hecht, and genogroup VII contains Yellowtail ascites virus and Marine Birnavirus [18, 61 
22-24]. 62 
IPNV vaccines have been available since 1995 and include the main immunogenic 63 
protein VP2 and other components of the virus. The protection shown in the trials 64 
reached more than 80% but despite the introduction of IPNV vaccines to the farmed 65 
stock, IPNV outbreaks were still reported. DNA vaccines have been developed as 66 
well but currently cannot be administered on a bigger scale for regulatory reasons [25, 67 
26]. IPNV outbreaks in Norwegian aquaculture continued up to 2010 and dropped 68 
from 2011 onward, when commercial salmon strains with an identified quantitative 69 
trait locus (QTL) for IPNV resistance became available [27]. IPNV resistant fish seem 70 
to be more effective for disease control than vaccines, as protective immune 71 
response in salmon can show big variations depending on their genetic background 72 
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and the IPNV strains involved [28]. IPNV vaccines used today are administered via 73 
intraperitoneal injection and are inactive whole virus vaccines or contain fragments of 74 
the major capsid protein VP2. 75 
This project studied the molecular epidemiology of IPNV on aquafarms in Scotland 76 
by genome sequence analysis of IPNV isolates spanning more than three decades 77 
(1982-2014). Several phylogenetic tools were employed to infer phylogeny and to 78 
track the evolution of the virus. 79 
 80 
  81 
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Results 82 
Sequencing results 83 
Fifty-seven IPNV samples from an extensive diagnostic collection from 1982 – 2014 84 
were randomly selected using equal probability of selection in MINITAB v.18.1.0 [29] 85 
and subjected to whole genome sequencing (WGS) according to sequencing 86 
protocols 1 or 2 (SP1, SP2) using high-throughput sequencing on the Illumina MiSeq 87 
(Illumina, USA) platform. 88 
The library fragment sizes ranged from 154 bp to 473 bp as determined by capillary 89 
electrophoresis. We observed significant differences (P<0.0001) in the initial RNA 90 
concentration measured by spectrometry (NanoDrop ND-1000, Thermo Fisher 91 
Scientific, USA) and in the ds-cDNA concentration measured on the Qubit 2.0 (Life 92 
Technologies, USA) (P<0.0001) between SP1 and SP2 with higher concentrations in 93 
samples processed with SP1. 94 
Sequencing reads were then used to estimate the genome coverage based on a 95 
reference genome for segment A and B (Figure 1A). There was no difference in the 96 
mean coverage between the two protocols (P=0.5203 segment A; P=0.0695 segment 97 
B). The maximum mean coverage for segment A was 18004.51 and for segment B 98 
38575.39. The minimum mean coverage for segment A was 0.88, and for segment B 99 
5.26 (Figure 1B). 100 
After assembling the IPNV genomes with the de novo approach, nucleotides at the 101 
termini were missing in most samples (Figure 1C) with a significant difference 102 
between the SPs (P=0.0143). For segment A missing nucleotides ranged from 1 bp 103 
to 92 bp at the 5’-end and 1 bp to 157 bp at the 3’-end, and for segment B from 1-104 
26 bp at the 5’-end and 1-37bp at the 3’-end. Therefore, for sequence comparison of 105 
all 57 IPNV isolates, only the ORFs were used.  106 
 107 
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Segment A showed a higher number of missing nucleotides than segment B. 108 
Whole genome de novo assemblies with no missing nucleotides at the termini and 109 
therefore without manual editing were achieved in samples IPNV60, 011, 019, 021, 110 
062, 066, 071 and 081 with both SPs. 111 
 112 
 113 
Phylogenetic analysis 114 
The 57 IPNV sequences determined from isolates in Scotland spread across 115 
genogroups I, II, III and V (Figure 2 and Figure 3). 116 
Distribution of genogroups revealed that 78.95% of the 57 IPNV sequences belong to 117 
genogroup V and only 5.26% to genogroup I. Of the remaining isolates 15.79% of 118 
segment A sequences cluster within genogroup III and 8.77% of segment B 119 
sequences cluster within genogroup II and 7.02% within the genogroup III indicating 120 
reassortment. 121 
 122 
VP2 analysis 123 
To analyse and compare the VP2 proteins, IPNV segment A sequences were aligned 124 
with the virulent reference Sp strain NVI-001 with focus on known virulence markers 125 
at amino acid residues 217, 221, 247, 252, 281, 282 and 319 [19, 30, 31]. 126 
All genogroup III strains shared the same amino acid residue pattern (Table 1). Two 127 
genogroup I isolates, IPNV060 from 1983 and IPNV061 from 1986, shared the same 128 
residue pattern whereas IPNV081 from 1994 has different amino acids in positions 129 
217, 247 and 282. Within the genogroup V strains, a range of amino acid variations 130 
in all decades and hosts was seen.  131 
Thirty-three isolates (58.93%) were found to belong to the persistent type (P217, 132 
T221), followed by 18 (32.14%) of low virulent (P217, A221) type. Only one 133 
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sequence (1.79%) shows a virulent pattern and no avirulent isolates (T217, T221) 134 
were found. Previously not described patterns were determined in one (1.79%) 135 
isolate (P217, S221) and shared by three (5.36%) more isolates (A217, T221), 136 
previously found in isolates in Chile and Mexico [32, 33]. The persistent types (P217, 137 
T221) were found in samples from all three decades extracted from S. salar as well 138 
as from O. mykiss. Low virulent types were exclusively extracted from S. salar 139 
starting in the 1990’s. 140 
Previous studies have shown that IPNV attenuates in chinook salmon embryo 141 
(CHSE-214) cell culture after several passages, with amino acid changes at VP2 142 
position 217 and 221 e.g. from virulent T217, A221 to avirulent T217, T221. All 143 
original diagnostic cultures had been performed on CHSE-214 cells (1-2 passages). 144 
To rule out, that the VP2 residues observed in the IPNV sequences determined here 145 
were not biased due to cell culture attenuation, 5 randomly selected IPNV isolates 146 
were additionally cultured for 3 passages on rainbow trout gonad (RTG-2) cells which 147 
are known not to introduce cell culture attenuation mutations in these specific VP2 148 
amino acid positions [19, 20].  149 
The analysis of the whole genome sequences obtained from the selected isolates 150 
cultured on RTG-2 cells (2-3 passages) showed no differences in amino acid 151 
positions P217 and T221 in the VP2 gene whether grown in CHSE-214 and TO or 152 
RTG-2 cells, and independent of the number of passages. 153 
 154 
Network analysis 155 
The network analysis of VP2 reveals a separate cluster representing early strains 156 
from the eighties connected to the main network cluster which is composed of 157 
persistent (P217, T221) and low virulent (P217, A221) IPNV isolates. Four samples, 158 
all of the persistent type (P217, T221), were located outside the main cluster (Figure 159 
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4). The only virulent T217, A221 isolate found in this study (sample IPNV053,) 160 
projects from the main cluster with only one amino acid difference. It derives directly 161 
from samples IPNV009 and IPNV013, with the amino acid composition PAAVTNA 162 
(Cluster 7, Table 1). 163 
 164 
Codon adaptation index analysis 165 
The codon adaptation index (CAI) was calculated for each IPNV protein to assess 166 
codon usage adaptation towards the salmon and the rainbow trout genome (Figure 167 
5). Proteins VP2, VP3 and VP4 have a CAI above 1.00, indicating adaptation to both, 168 
salmon and rainbow trout genomes, although the adaptation in VP2 and VP4 is 169 
comparably higher than in VP3. Furthermore, VP2 showed a significantly higher 170 
adaptation towards the salmon codon usages than that of the rainbow trout 171 
(P=4.867.10-5). There was also a significant difference in the CAI of VP5 between the 172 
two hosts (P=1.544.10-8). However, a completely random codon usage for both hosts 173 
was observed in VP5 (CAI < 1.00) indicating that there is no evidence of adaption of 174 
VP5 to the codon choices of either host. The polymerase showed only a minor codon 175 
usage adaptation (mean nCAI=1.003 for both hosts). 176 
Analysing CAI over time (Figure 6), an increase of codon usage adaptation was 177 
evident for both hosts in VP2 and VP4, with the highest increase in the 1980’s and 178 
1990’s. In VP3 a fluctuation in codon adaptation over time for both hosts could be 179 
observed. The polymerase showed fluctuations over time but no signs of overall 180 
codon adaptation to either host. 181 
Finally, CAI values for all IPNV proteins of the genomes of persistent (P217, T221) 182 
and low virulent (P217, A221) IPNV isolates were determined (see Supplementary 183 
Tables S1 and S2). Significant differences of the CAI for VP1 and VP2 were 184 
observed both in the genomes of the low virulent and persistent isolates towards the 185 
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salmon genome, whereas VP3 appeared to develop more against the rainbow trout 186 
genome.  187 
 188 
Selection analysis 189 
The results of the SLAC (Single Likelihood Ancestor Counting) analysis for positive 190 
selection show that only site 217 in the VP2 protein was under significant positive 191 
selection (P=0.087). Estimation of positively selected sites by applying MEME (Mixed 192 
Effects Model of Evolution) showed that all IPNV proteins have sites of positive 193 
selection (Supplement Table S3). In VP1 these sites were distributed across the 194 
gene. In VP2, sites 217, 248 and 315 were under positive selection. VP3 showed 195 
sites of selection within the RNA-binding domain. Sites under positive selection 196 
pressure in VP4 were not within the described active region of the protease. Sites 2-197 
68 in VP5 are all within the truncated region of the protein. 198 
 199 
Dinucleotide composition 200 
The results of the dinucleotide composition analysis show that for both segments, the 201 
CpG dinucleotides were underrepresented, with an CpGO/E value of 0.72 for Segment 202 
A and 0.74 for Segment B. 203 
  204 
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Discussion 205 
To analyse the phylogeny of IPNV samples from Scottish aquafarms from three 206 
decades, the whole genome of 57 IPNV isolates, without further clinical information, 207 
was sequenced by high-throughput sequencing. Only a few of the sequenced IPNV 208 
isolates from 1982-1992 belong to genogroups I, II or III. Over 70% of the sequenced 209 
IPNV isolates in this study belong to genogroup V, as also seen elsewhere [30, 34-210 
36]. 211 
Segment A/B reassortment of genogroup III/II viruses was seen in five isolates. 212 
Natural reassortment of genogroup I/II viruses was observed in 1999 in Canada and 213 
Spain [37],[38]. Cases of natural re-assortment were also reported in IBDV, a 214 
Birnavirus infecting chicken [39].  215 
Surveillance of IPNV prevalence since the seventies has accumulated evidence for 216 
transmission of IPNV from wild fish to aquafarm species and for spill back from farms 217 
to wild fish populations [40]. 218 
The detected IPNV re-assortants isolated from 1987-89, in the early aquaculture 219 
intensification phase in Scotland may have been generated in wild fish and then 220 
infected the farmed salmon and trout but were obviously not able to persist in the 221 
farmed salmonid populations. 222 
Infections with the high virulent (T217, A221) IPNV strains induce mortalities after 223 
sea water transfer in Atlantic salmon stressed from smoltification [41], whereas 224 
persistent (P217, T221) strains cause subclinical infections [19], [31]. The two most 225 
prevalent variants in this study were the persistent P217, T221 and the low virulent 226 
P217, A221 types. Only one virulent isolate T217, A221 was found.  227 
Similar results were obtained in studies by Ruane et al. [30] and Bain et al. [34]. 228 
Furthermore, it is known that variants with the persistent P217, T221 motif caused 229 
high mortality in rainbow trout [42]. 230 
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 231 
Only two amino acid substitutions are required to move from the persistent to the 232 
virulent type in VP2 (Figure 7), and therefore there is a potential for virulent strains 233 
emerging in high density farmed salmonids due to stress or other selection pressures. 234 
Persistent P217, T221 types prevailed in the time before vaccine introduction in 1995. 235 
After 1995 a switch from persistent P217, T221 to low virulent P217, A221 occurred, 236 
with a continuous increase of the low virulent type over the decades (Figure 7).  The 237 
IPNV resistant QTL has been shown to block the entry of the T217, A221 variant, in 238 
infected cells and in infected fish [43, 44]. To understand if in spite of this anymore 239 
T217, A221 IPNV types are currently evolving in QTL fish in Scotland, it would be 240 
necessary to study more recent isolates. In Norway the T217, A221 type was 241 
detected in the mid-90s, and dominated isolates from 1999. Recently persistent P217, 242 
T221 types have been isolated from groups of fish carrying the IPN-QTL in northern 243 
Norway (Oystein Evensen personal communication). Since there was no clinical 244 
information available for the isolates in this study, it is not possible to verify the 245 
pathogenic nature of the isolates. 246 
A study in Norway in 2004 [45] demonstrated that amino acid substitutions can occur 247 
from the pathogenic to the low virulent type in IPNV isolates from field outbreaks with 248 
T217, A221 changing to T217, T221 in CHSE-214 cell culture after 2-3 passages and 249 
to P217, A221 after 13 passages post infection primarily describing cell adaptation. 250 
A reversion of a non-virulent T217, T221 IPNV strain to a high virulent T217, A221 251 
IPNV strain was found to be induced by stress in salmon [46]. 252 
The high number of persistent and low virulent strains indicates that the virus 253 
predominantly replicates at a level not harming the host, avoiding a strong immune 254 
response and possibly extended shedding of the virus. This was already suggested 255 
 13 
for shrimp viruses, where it was shown that changes in the codon usage allowed a 256 
shift towards lower virus replication to avoid hosts immune response [47]. 257 
The efficiency of IPNV vaccines is mainly assessed in terms of their ability to 258 
suppress disease symptoms and improve fish survival [48]. In one study IPNV 259 
isolated from vaccinated farmed salmon in Norway were almost all of the high 260 
virulent T217, A221 type. When these isolates were used in challenge experiments in 261 
naïve fish they induced mortality of up to 56% and isolates of the low virulent P217, 262 
A221 type induced a mortality of more than 30%, showing that vaccinated fish 263 
harbour virulent strains. These observations indicate failure of the IPN-vaccines in 264 
the sense that they are non-sterilising vaccines, which do not completely inhibit IPNV 265 
replication and therefore permit low level virus evolution in vaccinated salmon [49, 266 
50]. 267 
With a typical RNA virus mutation rate of 10-2 - 10-5 substitutions (mutations)/site/year, 268 
IPNV shows to acquire more non-synonymous than synonymous mutations [51, 52],  269 
the IPNV genome as a whole appears to be developing towards co-existence with 270 
the host, in spite of the specific selection pressure on the variable region of VP2 [45]. 271 
In order to analyse IPNV adaptation to salmonid host codon usage (S. salar and O. 272 
mykiss), CAI was calculated for each of the 5 IPNV proteins towards both hosts over 273 
time and for all persistent and low virulent strains. 274 
The major capsid protein VP2 and the protease VP4 show the highest CAIs in both 275 
hosts. The adaptation of VP2 in S. salar is significantly higher than in O. mykiss.  276 
The 20-fold higher annual production of salmon (162,817 tons in 2016) in comparison 277 
to rainbow trout (8,096 tons in 2016) farmed in Scotland [53], allows for a much 278 
higher number of IPNV replication cycles in the salmon population and consequently 279 
more scope for codon adaptation of VP2 to its salmon host.  280 
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The adaption of the codon usage in VP2 and VP4 ensures an efficient translation of 281 
the capsid protein, and the protease. Interestingly, the fastest increase of CAI over 282 
time for VP2 and VP4 correlates with the biggest increase of salmon farming in the 283 
1980s (98.15%) and the 1990s (74.91%) [54]. The CAI for the VP1 (RdRp) is very 284 
low which is plausible, as the RdRp is strongly conserved within RNA viruses [55]. 285 
VP3 showed only minimal codon adaptation but has the highest mutation/kb rate of 286 
all IPNV proteins with preferred non-synonymous mutations [45].  VP3 blocks the 287 
hosts’ immune response during infection by suppressing IFNα induction [16]. A non-288 
optimised VP3 as observed here might be an important toggle to keep innate 289 
immune response at bay for just the right level of IPNV replication. 290 
The CAI values for VP5 are lower than 1, indicating no codon adaptation. Previous 291 
research on IBDV showed that the ORF of VP5 has a different base usage than the 292 
ORF of VP2 suggesting that the original ORF was overprinted to create a de novo 293 
gene [56, 57]. Analysis of the IPNV VP5 sequences confirms this for IPNV. De novo 294 
genes are usually linked to viral pathogenicity and indeed VP5 is a homologue of the 295 
anti-apoptotic Bcl-2 family and shuts down hosts apoptosis system and together with 296 
VP4 inhibits IFN signalling [17, 58].  297 
Some wild IPNV isolates express a truncated form of VP5 and some isolates do not 298 
even encode the VP5 protein but still replicate and induce mortality, thus the protein 299 
appears to be not essential for virus replication [61-64]. Due to its anti-apoptotic 300 
function VP5 might have been selected in densely farmed populations to maintain 301 
low level replication in vaccinated hosts. 302 
Genes of mammalian viruses that encode structural proteins not involved in hosts 303 
immune system interaction show higher CAI values than non-structural proteins such 304 
as the RdRp [59]. The high CAI of VP2 indeed suggests adaptation to the host’s 305 
codon usage in order to increase translational efficiency. VP2 however also contains 306 
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epitopes in the variable domain at position 183-335, which are under selection 307 
pressure (Table S3). 308 
 309 
The CAI of Infectious salmon anaemia virus (ISAV) genes is high for structural genes 310 
N, M1 but highest for non-structural protein NS1 [60], suggesting that fish viruses 311 
may not follow the general adaptation models that were suggested for mammalian 312 
viruses. A study of CAI in shrimp viruses revealed higher CAI values only in non-313 
structural proteins indicating that aquatic viruses of invertebrates also adapt to their 314 
host in a different way than shown for mammalian viruses [47]. 315 
Beside the CAI the CpG content can be considered as another adaptation feature, 316 
and invertebrate infecting dsRNA viruses have a higher CpG abundance than 317 
vertebrate infecting dsRNA viruses apparently because the CpGO/E of invertebrates 318 
themselves is 1.02 compared to 0.47 for vertebrates [61]. This suggests indeed a 319 
difference in host adaptation with invertebrates infecting dsRNA viruses. Other single 320 
strand DNA shrimp viruses also de-optimize their codon bias to not compete with the 321 
host translational system, thus possibly supporting a low replication strategy to avoid 322 
immune defence [47]. The CpG dinucleotide is under-represented in both IPNV 323 
segments with a CpGO/E=0.72 and 0.74 for segment A and B respectively. These 324 
values are lower than the estimated mean CpGO/E=0.88 for vertebrate infecting 325 
dsRNA viruses, representing a normal or an over-representation of CpG motifs [61]. 326 
It is possible that IPNV uses a strategy more similar to invertebrate dsRNA viruses, 327 
as viral replication on a low level ensures host survival and therefore, survival of the 328 
virus.  329 
CpGs are also a pathogen associated molecular pattern (PAMP) recognised by 330 
innate immunity receptors such as Toll-like receptor 9. Small RNA viruses show CpG 331 
suppression in their genome, which sustains their replication as shown for IMNV with 332 
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a CpGO/E value of 0.61 [47, 62]. It is hypothesized that the IPNV CpGO/E of 0.72 and 333 
0.74 indicates the same strategy. Possible viral immune escape in fish hosts is 334 
supported by the observation that Atlantic salmon leucocytes produce antiviral 335 
cytokines after stimulation with unmethylated CpG [63]. 336 
In order to determine sites of the IPNV genomes under selection pressure a positive 337 
selection analysis on each IPNV protein sequence alignment of the 57 sequenced 338 
IPNV samples was performed using two different algorithms. 339 
The MEME calculation confirmed the SLAC calculation for VP2 but also revealed 340 
positive selection sites in each IPNV protein. Site 217 is one of the two virulence 341 
signature sites in the variable VP2 region. Four additional sites determined by MEME 342 
(241, 242, 248 and 315) are also within the variable VP2 domain (183-335). The 343 
immune pressure in this region can therefore result in changes to virulence.  344 
The network analysis of non-homologous amino acid sequences within the VP2 345 
hypervariable region of genogroup V isolates (Figure 4), shows that the main cluster 346 
of persistent and low virulent isolates evolves in the constraints of a certain sequence 347 
space from which, as shown by strains IPNV072 or 014, variants with specific new 348 
virulence amino acid signatures or even a virulent strain IPNV053 can emerge by 349 
acquiring the second amino acid change.  350 
VP1(RdRp) sites calculated under positive selection pressure were mostly found 351 
outside conserved motifs I-VI. Only site 316 in motif I and site 467 in motif IV 352 
experienced positive selection pressure. These conserved motifs are crucial for the 353 
RdRp function [64]. 354 
VP3 showed one site under positive selection pressure within the self-binding domain 355 
and one within the dsRNA binding domain. Otherwise, no sites were under selection 356 
pressure within the RdRp binding domain, indicating that this region is quite 357 
conserved. 358 
 17 
In VP4 no catalytic active sites are affected by positive selection. It is quite obvious 359 
that these sites are crucial to protease function and cannot undergo changes. 360 
In VP5 the first 6 sites under positive selection pressure are within the truncated 361 
region of the protein indicating high local variability. As stated above VP5 appears 362 
not being essential, as some IPNVs have a truncated VP5, and some IPNVs lack 363 
VP5 but still are capable to induce mortality [65-68]. The role of VP5 remains to be 364 
elucidated. 365 
 366 
Conclusion 367 
The phylogenetic and genomic analyses of IPNV performed in this study indicate that 368 
selection pressures result in evolution of IPNV in farmed salmon and rainbow trout by 369 
(i) reassorting the dsRNA segments between different genogroups, (ii) changes 370 
within the hypervariable region in the VP2 protein, in favour of virulence beneficial to 371 
low level virus replication, (iii) adapting the codon usage of the major capsid protein 372 
VP2 and the VP4 for better maturation. These processes can lead to the emergence 373 
of new virulence amino acid signatures in VP2 and even to the emergence of fully 374 
virulent strains. 375 
These mechanisms are possible due to (i) a high mutation rate of IPNV, (ii) high virus 376 
replication and enrichment in dense fish populations on farms and interactions with 377 
wild animals, (iii) the use of obviously non-sterilising IPNV vaccines not preventing 378 
low level IPNV replication in farmed vaccinated fish. 379 
The high prevalence of persistent and low virulent strains shows that IPNV is 380 
tentatively evolving towards the host to lower replication levels with reduced disease 381 
impact on the host but sustained virus shedding. 382 
 383 
Methods 384 
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Cell culture 385 
CHSE-214 [69] and TO (Atlantic salmon head kidney leucocytes) cells [70] were 386 
used to propagate IPNV isolates. RTG-2 cells [71] were used to test that attenuation 387 
had not influenced IPNV sequence outcome. CHSE-214 and TO cell lines were 388 
grown at 22°C and 4% CO2 in Eagle’s Minimum Essential Medium (EMEM) with 10% 389 
Foetal Bovine Serum (FBS), 1x non-essential amino acids and 2 μM L-Glutamine. 390 
RTG-2 cells were grown at 22°C in Leibovitz-15 medium (L-15) with 10% Foetal 391 
Bovine Serum (FBS). In order to maintain a healthy and even monolayer cells were 392 
passaged regularly. 393 
 394 
Fifty-seven IPNV isolates (Table S4) were defrosted and kept on ice. Simultaneous 395 
inoculation or inoculation via adsorption was performed using 24 well plate. 396 
HBSS+2% FBS was used as a diluent and as a negative control. The plate was 397 
incubated at 15°C and 1% CO2 (CHSE-214, TO) or without CO2 (RTG-2). Every day 398 
the plate was examined for cytopathic effect (CPE). 399 
Supernatant of wells with a visible CPE was collected and centrifuged at 2500xg and 400 
4°C for 15 min in order to be passaged into a 25 cm2-tissue culture flask. The flasks 401 
were incubated for 1h at 15°C and 1% CO2 (CHSE-214, TO) or without CO2 (RTG-2) 402 
for inoculation. After incubation, the inoculum was discarded and 5 mL EMEM or 403 
Leibovitz L-15 medium +10% FBS media were added respectively. The flasks were 404 
incubated at 15°C and and 1% CO2 (CHSE-214, TO) or without CO2 (RTG-2) and 405 
examined every day for CPE. 406 
When a full CPE was visible in the 25 cm2-tissue culture flask, the supernatant was 407 
collected into a 15 mL falcon tube and centrifuged at 2500xg and 4°C for 15 min. The 408 
supernatant was filtered through a 0,2 μm sterile filter and stored at -70°C or used 409 
immediately for downstream applications. 410 
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 411 
RNA extraction, ds-cDNA synthesis and sequencing 412 
Sequencing protocol 1 (SP1): IPNV RNA was extracted and processed as described 413 
[72]. Library preparation and normalization was prepared using Illumina Nextera XT 414 
DNA Library Preparation Kit (Illumina, UK). The library was checked on the 415 
Bionalyzer following the manufacturer’s instructions before it was sequenced on the 416 
MiSeq (Illumina, UK). Paired-end sequencing with 2 x 75 bp was performed 417 
according to the MiSeq Reagent Kit (v3; 150 cycles) protocol.  418 
Sequencing protocol 2 (SP2): IPNV RNA was extracted via Agencourt RNAdvance 419 
Blood Kit (Beckman Coulter, UK) according to Agencourt RNAdvance Blood 2 mL 420 
Tube Protocol with following changes: (i) 400 µL of filtered cell culture supernatant 421 
was used. (ii) The DNase step was performed by adding 100 μL of the DNase 422 
solution, containing 85 μL water, 10 μL 10x DNase buffer and 5 μL DNase I and 423 
incubating at 37°C for 5 min. Eluted RNA was stored at -70°C until further processing. 424 
RNA concentration was estimated using the NanoDrop. 425 
10 µL of extracted RNA were converted into ss-cDNA using the Super Script III RT 426 
Kit (Life Technologies, UK) and ds-cDNA was synthesised using the NEBNext® 427 
mRNA Second Strand Synthesis Module (New England Biolabs, UK) by adding 428 
20 µL of ss-cDNA to 60 µL of the ds-cDNA master mix and following the 429 
manufacturer’s instructions. 430 
Ds-cDNA was cleaned by adding 80 µL of Ampure XP beads (Beckman Coulter, UK) 431 
per sample (1x) and incubation for 5 min at room temperature. The sample was 432 
placed into a magnet rack, so the clear supernatant could be discarded. The 433 
magnetic beads pellet was washed twice with 200 µL of freshly prepared 70% 434 
Ethanol, while keeping the tube in the magnet and dried in the magnet for 5 min at 435 
room temperature to remove all ethanol traces. The pellet was eluted in 25 µL 436 
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molecular grade water and transferred into a new Eppendorf DNA LoBind 1.5 mL 437 
tube. The DNA was stored at -20°C until used for library preparation as described in 438 
SP1. 439 
Several approaches to improve the sequencing yield in the ds-cDNA synthesis steps 440 
including use of single strand binding protein GP32, additional cDNA primers for the 441 
3`-end, providing hexamers and dNTPs and incubation of RNA at 75°C and 95°C 442 
before synthesis did not significantly improve results. 443 
 444 
Raw reads were filtered in order to remove adapters and low-quality reads by using 445 
PRINSEQ v.0.20.4 [73] and TRIMMOMATIC v.0.35 [74]. DECONSEQ v.0.4.3 was 446 
used to remove contaminating reads from other organisms (databases: Salmon, 447 
Trout, PhiX) [75]. Down sampling was performed with KHMER v.2.0, which 448 
eliminates redundant short reads. After that the reads were used for a de novo 449 
assembly via SPADES v.3.7.1 [76]. In parallel, reference-based assemblies were 450 
created using TANOTI v.1.2 [77] and STAMPY v.1.0.28 [78] with NC_001915.1 451 
(segment A) and NC_001916.1 (segment B) as reference sequences. The resulting 452 
sequences were compared using BLAST v.2.6.0+ (blastn, against reference 453 
NC_001915.1 and NC_001916.1) to find the most complete genome [79]. De novo 454 
assembled sequences were preferred as potential insertions, deletions and 455 
rearrangement of the genome are taken into account. The reference-based assembly 456 
was used to eventually extend the de novo sequences at the genome termini. 457 
BOWTIE2 v.2.3.4.1 [80] and SAMTOOLS v.1.3.1 [81] were used to map the MiSeq 458 
reads to the assembled genome to evaluate the coverage of the assembled 459 
segments. 460 
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For single protein analysis, the sequences were aligned to the reference genome 461 
using CLUSTAL OMEGA v.1.2.4 [82, 83] and the genome annotation was transferred 462 
from the reference sequence using RATT [84]. 463 
 464 
Phylogenetic analysis 465 
BEAUTI v1.8.3 was used to analyze the sequences of segment A and segment B of 466 
57 IPNV isolates and additional reference genomes (Supplemental Table S5 and S6) 467 
with the following parameters: 10,000,000 chains per cycle with every 1000th chain 468 
being recorded, using the HKY substitution model, a strict clock and a coalescent 469 
tree [85, 86]. BEAST v1.8.3 was used to perform the calculation of the tree [87]. 470 
In order to assess if IPNV has been adapting its codon usage in any of the 5 IPNV 471 
proteins to that of the host organisms salmon (S. salar) or rainbow trout (O. mykiss) 472 
to optimise virus protein translation, a codon adaptation analysis was performed with 473 
limit of significance of P≤0.05 according to the protocol [88], [89, 90]. 474 
To perform positive selection calculation on HYPHY v.2.2, aligned sequences of 57 475 
IPNV protein sequence alignments with a corresponding tree file were used to 476 
perform MEME and SLAC analysis with limit of significance of P≤0.1 according to the 477 
protocol [91]. 478 
To estimate the abundance of dinucleotides in IPNV segment A and B sequences, 479 
EMBOSS COMPSEQ v.1.12.0 [92] was used. The expected frequencies were 480 
calculated based on the single base frequency of input sequence and not by 481 
assumption, that every dinucleotide has equal frequency. A CpG abundance is 482 
considered low when CpG observed/expected (CpGO/E) ≤1 and high when CpGO/E ≥1. 483 
SPLITSTREE v.4.14.6 was used to generate Neighbor Network of the IPNV VP2 484 
protein using amino acid alignments containing only non-homologue amino acids [93]. 485 
 486 
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Tables 806 
Table 1 VP2 characteristic variable residue pattern of sequenced IPNV isolates compared to the 807 
virulent reference strain excluding IPNV032. 808 
Cluster Sequence ID Collection 
Year 
Genogroup VP2 Amino acid position 
    217   221   247   252     281     282       319  
1 IPNVV006, 
011, 019, 
063, 064, 
065, 066, 
068, 069 
1982, 1986, 
1987, 1988, 
1989, 1992 
III P T P A T A A  
2 IPNV007, 
008, 021, 
062, 026, 
070, 071, 
073, 075, 
076, 081, 
083, 084, 
107, 001, 
003, 039 
1984, 1987, 
1990, 1992, 
1993, 1994, 
1997, 1999, 
2000, 2002, 
2008 
I, V P T A N T N A  
3 IPNV027 1989 V P T A N T N V  
4 IPNV024, 
031, 057, 
047, 048, 050 
2005, 2006, 
2013, 2014 
V P T A V T N A  
5 IPNV072 1992 V P A A T T N A  
6 IPNV087, 
088, 090, 111 
1997, 1998, 
1999 
V P A A I T N A  
7 IPNV009, 
010, 013, 
018, 030, 
035, 051, 
052, 054, 
055, 056, 
049, 058 
2003, 2004, 
2006, 2007, 
2010, 2011, 
2012, 2014 
V P A A V T N A  
8 IPNV060, 
061, 082 
1983, 1986, 
1996 
I, V A T E N T A A  
9 IPNV014 2004 V P S A V T N A  
10 IPNV053 2011 V T A A V T N A  
11 Santi et al., 
2004 [19] 
2000 V T A T V T N A  
 809 
 810 
 811 
Figures 812 
 30 
Figure 1 A. Forward and reverse reads recovered from IPNV samples processed with the SP1 or the 813 
SP2. B. Mean coverage of Segment A and B for 57 processed IPNV samples with the SP1 or SP2. C 814 
Missing terminal nucleotides of both segments of IPNV samples processed with the SP1 or the SP2 815 
after de novo assembly. Values were analysed using the Mann-Whitney test.  816 
 817 
 31 
 818 
Figure 2. Phylogenetic classification of 57 IPNV isolates based on segment A sequences. Genogroup VII consists of AY98 , YTAV_Y6 and GC1. 819 
Yellowtail ascites virus is currently grouped as a species distinct from IPNV in the genus Aquabirnavirus by ICTV. However even ICTV states: “The 820 
extremely close genetic relationship between the species, suggests that there may be a case for combining them into one“. The unrooted tree was 821 
calculated using BEAST with 10,000,000 chains per cycle with every 1000th chain being recorded. Posterior probability values are shown for different 822 
genogroups at corresponding nodes in percent. The scale represents 0.02 substitutions per nucleotide site. 823 
 32 
 824 
 825 
Figure 3. Phylogenetic classification of 57 IPNV isolates based on segment B sequences. The 826 
unrooted tree was calculated using BEAST with 10,000,000 chains per cycle with every 1000 th chain 827 
being recorded. Posterior probability values are shown for different genogroups at corresponding 828 
nodes in percent. The scale represents 0.06 substitutions per nucleotide site. 829 
 830 
 831 
 832 
Figure 4. Neighbor Network of the VP2 protein for genogroup V IPNV samples based on non-833 
homologous amino acid alignment. The scale bar represents the split support for the edges. Sample 834 
IPNV053 (red) is the only virulent type (T217, A221). Green samples represent persistent type (P217, 835 
T221), purple low virulent (P217, A221) and blue not assigned types (A217, T221 and P217, S221). 836 
 837 
 838 
Figure 5. IPNV proteins have different codon usage adaptation indexes towards their hosts of Atlantic 839 
salmon and rainbow trout. Normalized CAI values above 1.00 support evidence of codon usage 840 
adaptation to that specific host. Asterisks indicate a significant difference (p<0.05) between hosts. 841 
 842 
    843 
 844 
Figure 6. Temporal CAI analysis of each IPNV open reading frame shows differences of codon usage 845 
adaptation indexes between the IPNV host genome of Atlantic salmon and rainbow trout from 1980 to 846 
2010. Normalized CAI values above 1.00 support evidence of codon usage adaptation to that specific 847 
host. Asterisks indicate a significant difference (p<0.05) between hosts. 848 
 849 
Figure 7 Distribution of variants of 56 sequenced IPNV strains in each decade. Due to not assigned 850 
residues one isolate was excluded. Persistent type (P217, T221) 33 strains (58.93%), low virulent 851 
(P217, A221) 18 strains (32.14%) virulent type 1 strain (1.79%).  852 
 33 
 853 
 854 
  855 
 34 
Supplement 856 
 857 
Table S1 Significant differences in CAI values between hosts against 858 
a sample variant persistent (P) type and low virulent (LV) type; 859 
significance level p ≤ 0.05. 860 
Protein Host Comparison P=value 
RdRp O. mykiss P - LV 0.00037 
S. salar P - LV 0.00043 
VP2 O. mykiss P - LV 0.014 
S. salar P - LV 0.01627 
VP3 O. mykiss P - LV 0.048 
 861 
Table S2 Significant differences in CAI values persistent (P) and low 862 
virulent (LV) type of samples against host species; significance level p 863 
≤ 0.05. 864 
Protein Virulence type Comparison P=value 
VP2 P O. mykiss – S. salar 0.01589 
 LV O. mykiss – S. salar 8.17 10-6 
VP5 P O. mykiss – S. salar 7.26 10-6 
 LV O. mykiss – S. salar 0.00088 
 865 
 866 
Table S3 Results of site-specific positive and diversifying selection analysis of all IPNV proteins for all 867 
57 sequenced samples using MEME on HYPHY, applying the MG94xREV codon model. P describes 868 
the P=value (p≤0.1) for positive selection at one site. 869 
 
RdRp/VP1 
 
 
VP2 
 
VP3 
 
VP4 
 
VP5 
Codon P=value Codon P=value Codon P=value Codon P=value Codon P=value 
 
          
50 0.01 195 0.02 66 0.10 37 0.09 2 0.01 
 35 
81 0.00 208 0.02 145 0.10 46 0.01 13 0.19 
82 0.00 217 0.00   131 0.04 17 0.03 
140 0.04 241 0.00   212 0.09 36 0.09 
226 0.05 242 0.03   218 0.05 53 0.07 
232 0.04 248 0.00     68 0.09 
316 0.00 315 0.09     98 0.08 
358 0.07 333 0.07     106 0.04 
368 0.05       111 0.08 
467 0.01         
687 0.07         
699 0.07         
737 0.09         
 870 
Table S4 Sequenced IPNV samples. NA=not assigned, Atlantic salmon (Salmo salar), rainbow trout 871 
(Oncorhynchus mykiss), brown trout (Salmo trutta), turbot (Scophthalmus maximus). 872 
Sequence 
ID 
Collection 
Year 
Confirmed 
Serotype 
Cell line Host Origin Region 
IPNV006 1982 NA CHSE-214 S. salar UK Scotland, Argyll 
IPNV060 1983 NA CHSE-214 NA NA NA 
IPNV007 1984 NA CHSE-214 O. mykiss UK Scotland, Borders 
IPNV008 1984 NA CHSE-214 O. mykiss  UK Scotland, Borders 
IPNV011 1986 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV061 1986 Sp CHSE-214 S. 
maximus 
NA NA 
IPNV019 1987 NA CHSE-214 O. mykiss UK Scotland, Highlands 
IPNV021 1987 NA CHSE-214 O. mykiss UK Scotland, Strathclyde 
IPNV062 1987 NA CHSE-214 S. salar NA NA 
IPNV063 1987 Ab CHSE-214 S. salar NA NA 
IPNV064 1987 Ab CHSE-214 NA UK Scotland, Highlands 
IPNV065 1987 Ab CHSE-214 NA UK Scotland, Highlands 
IPNV066 1988 Ab CHSE-214 S. salar UK Scotland, Highlands 
IPNV027 1989 NA CHSE-214 O. mykiss UK Scotland, Borders 
IPNV032 1989 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV068 1989 Ab CHSE-214 S. salar UK Scotland, Highlands 
IPNV026 1990 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV069 1992 Ab CHSE-214 S. salar NA NA 
IPNV070 1992 Sp CHSE-214 NA Norway Norway 
IPNV071 1992 Sp TO NA UK Scotland, Argyll 
IPNV072 1992 Sp CHSE-214 NA UK Scotland, Shetland 
IPNV073 1993 Sp CHSE-214 S. salar NA NA 
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IPNV075 1993 Sp TO S. salar Norway Norway 
IPNV076 1994 Sp TO S. salar NA NA 
IPNV081 1994 NA CHSE-214 S. salar NA NA 
IPNV082 1996 Sp CHSE-214 S. salar NA NA 
IPNV083 1997 Sp CHSE-214 S. salar NA NA 
IPNV084 1997 Sp CHSE-214 S. salar NA NA 
IPNV087 1997 Sp CHSE-214 S. salar NA NA 
IPNV088 1997 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV090 1998 Sp CHSE-214 S. salar NA NA 
IPNV107 1999 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV111 1999 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV001 2000 Sp TO S. salar NA NA 
IPNV003 2002 Sp TO S. salar NA NA 
IPNV009 2003 Sp CHSE-214 S. salar UK Scotland, Argyll 
IPNV010 2003 Sp TO S. salar NA NA 
IPNV013 2004 Sp TO S. salar UK Scotland, Argyll 
IPNV014 2004 Sp CHSE-214 NA NA NA 
IPNV018 2004 Sp TO NA NA NA 
IPNV024 2005 Sp TO S. salar NA NA 
IPNV030 2006 Sp TO S. salar NA NA 
IPNV031 2006 Sp TO S. trutta UK Scotland, Shetland 
IPNV035 2007 Sp CHSE-214 S. trutta UK Scotland, Shetland 
IPNV039 2008 Sp CHSE-214 S. salar NA NA 
IPNV051 2010 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV052 2011 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV053 2011 NA CHSE-214 S. salar UK Scotland, Strathclyde 
IPNV054 2011 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV055 2012 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV056 2012 NA CHSE-214 S. salar UK Scotland, Orkney 
IPNV057 2013 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV047 2014 Sp CHSE-214 NA NA NA 
IPNV048 2014 Sp CHSE-214 NA NA NA 
IPNV049 2014 Sp CHSE-214 NA NA NA 
IPNV050 2014 Sp CHSE-214 NA NA NA 
IPNV058 2014 NA CHSE-214 S. salar UK Scotland, Outer 
Hebrides 
 
 873 
Table S5 Reference strains used for phylogenetic analysis of segment A; NA means not assigned. 874 
 
Strain 
 
GenBank 
 
Geographical 
Origin 
 
 
Host 
 
Reference 
Ca3 AF342734 Canada Salvelinus alpinus [18] 
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Connecticut1 JF440810 USA Salmo spec. [94] 
Ca2 AF342733 Canada Oncorhynchus spec [18] 
TABV2013 KP268663.1 Australia Oncorhynchus mykiss [95] 
TABV1998 NC_028252.1 Australia Gadus spec [95] 
1146 AJ489222.1 Spain Trout (not further 
specified) 
[96] 
Sp KF279643 Iran Trout (not further 
specified) 
[97] 
Gre NA Turkey Oncorhynchus mykiss unpublished 
SDF4 NA Turkey Oncorhynchus mykiss unpublished 
1054 NA Turkey Oncorhynchus mykiss unpublished 
Sp AF342728 Denmark Trout (not further 
specified) 
[18] 
Ireland HQ457197.1 Ireland Salmon salar [36] 
DPL AY026485.1 Thailand Snakehead fish 
(Channidae) 
[18] 
Fr21 AY026483.1 France Trout (not further 
specified) 
[18] 
OV2 AY026484.1 England, UK Oyster (Ostreidae) [18] 
N1 D00701 Norway Salmon salar [98] 
Chile HQ457169 Chile Salmon (not further 
specified) 
[36] 
Norway HQ457199 Norway Salmon salar [36] 
Sp vir. AY374435.1 Norway Salmon salar / 
Oncorhynchus mykiss 
[19] 
Ab AF342729 Denmark Trout (not further 
specified) 
[18] 
2284 AJ489223 Spain Trout (not further 
specified) 
[96] 
Ab L40580.1 Denmark NA [99] 
CVHB1 AY026489.1 Taiwan Clam (not further 
specified) 
[18] 
S AY026487 Taiwan Eel (Anguilliformes) [18] 
V AY026486.1 Japan Eel (not further 
specified) 
[18] 
PV AY026488.1 Taiwan Perch (Perca) [18] 
Ca1 AF342732 Canada Trout (not further 
specified) 
[18] 
ASV AY026490.1 Canada Salmon (not further 
specified) 
[18] 
Te2 AF342731 England, UK Tellina (Tellina) [18] 
AY98 AY283785.1 Japan Ayu (Plecoglossus) [24] 
YTAV_Y6 AY283781 Japan Yellowtail (Seriola) [24] 
GC1 AY064396.1 Korea Rockfish (not further 
specified) 
unpublished 
Ja AF342735.1 Canada Trout (not further 
specified) 
[18] 
Reno AY026345 USA Trout (not further 
specified) 
[18] 
Ja2310 AJ489225 Spain Salmon (not further 
specified) 
[96] 
HL1 D26526.1 Korea NA [100] 
Ja NC_001915.1 Canada Trout (not further [13] 
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specified) 
VR299 AF343572 USA Trout (not further 
specified) 
[18] 
93 AY026346.1 USA Trout (not further 
specified) 
[18] 
11 AY026347.1 USA Trout (not further 
specified) 
[18] 
Mexico JX174178 Mexico Trout (not further 
specified) 
unpublished 
114 AY026348 USA Trout (not further 
specified) 
[18] 
91 AF343570 USA Trout (not further 
specified) 
[18] 
Buhl AF343573 USA Trout (not further 
specified) 
[18] 
DryMills AF343571.1 USA Trout (not further 
specified) 
[18] 
WB AF342727 USA Trout (not further 
specified) 
[18] 
VTAB NC_030242.1 Australia Oncorhynchus mykiss [95] 
He AF342730 Germany Esox lucius [18] 
 875 
  876 
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Table S6 Reference strains used for phylogenetic analysis of segment B; NA means not assigned. 877 
 
Strain 
 
GenBank 
 
Geographical 
Origin 
 
 
Host 
 
Reference 
Mexico EU665685.1 Mexico Trout (Oncorhynchus) unpublished 
HL1 D26527.1 Korea NA [101] 
2310 AJ489241 Spain Salmon (Salmo) [96] 
Ja Duncan NC_001916 Canada Trout [13] 
WB AF078669.1 USA NA [102] 
YTAV-06 AB281674 Japan Yellowtail (Seriola) [103] 
POBV EU161286.1 China Japanese Flounder 
(Paralychthys 
olivaceus) 
[104] 
YTAV-NC1 AY129666 Korea Japanese Flounder 
(not further specified) 
[105] 
Y-6 AY129662 Japan Yellowtail (not further 
specified) 
[105] 
AY-98 AY123970 Japan Ayu (Plecoglossus) unpublished 
VTAB NC_030244.1 Australia Rainbow Trout  [95] 
He JF734351.1 Spain Pike (Esox Lucius) [106] 
Ca2 JF734354 Canada Trout (not further 
specified) 
[106] 
Ca3 JF734355 Canada Trout (not further 
specified) 
[106] 
Ca1 JF734353 Canada Trout (not further 
specified) 
[106] 
Ab1 AM114033.1 NA NA [96] 
Ab2 JF734350.1 NA Trout (not further 
specified) 
[106] 
2284 AJ489239.1 Spain Rainbow Trout 
(Oncorhynchus 
mykiss) 
[96] 
Sp1 AJ622823 France Trout [107] 
IRIPNV KC900161.1 Iran Rainbow Trout [97] 
Gre NA Turkey Rainbow Trout unpublished 
SDF4 NA Turkey Rainbow Trout unpublished 
1054 NA Turkey Rainbow Trout unpublished 
Sp3 AM889221 Denmark Trout (not further 
specified) 
[108] 
Sp2 M58757.1 NA NA [109] 
Sp122 AY354524.1 Norway NA [110] 
Chile KU609618 Chile Salmon (not further 
specified) 
[111] 
Sp116 AY354523 Norway NA [110] 
Sp103 AY354522.1 Norway NA [110] 
TABV2013 KP268678.1 Australia Rainbow Trout [95] 
TABV1998 NC_028253.1 Australia Cod (Gadus) [95] 
Te AJ920336 UK Tellina (Tellina tenuis) [112] 
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Supplement 
 
Table S1 Significant differences in CAI values between hosts against 
a sample variant persistent (P) type and low virulent (LV) type; 
significance level p ≤ 0.05. 
Protein Host Comparison P=value 
RdRp O. mykiss P - LV 0.00037 
S. salar P - LV 0.00043 
VP2 O. mykiss P - LV 0.014 
S. salar P - LV 0.01627 
VP3 O. mykiss P - LV 0.048 
 
Table S2 Significant differences in CAI values persistent (P) and low 
virulent (LV) type of samples against host species; significance level p 
≤ 0.05. 
Protein Virulence type Comparison P=value 
VP2 P O. mykiss – S. salar 0.01589 
 LV O. mykiss – S. salar 8.17 10-6 
VP5 P O. mykiss – S. salar 7.26 10-6 
 LV O. mykiss – S. salar 0.00088 
 
 
 
 
 
 
 
 
 
 2 
Table S3 Results of site-specific positive and diversifying selection analysis of all IPNV proteins for all 
57 sequenced samples using MEME on HYPHY, applying the MG94xREV codon model. P describes 
the P=value (p≤0.1) for positive selection at one site. 
 
RdRp/VP1 
 
 
VP2 
 
VP3 
 
VP4 
 
VP5 
Codon P=value Codon P=value Codon P=value Codon P=value Codon P=value 
 
          
50 0.01 195 0.02 66 0.10 37 0.09 2 0.01 
81 0.00 208 0.02 145 0.10 46 0.01 13 0.19 
82 0.00 217 0.00   131 0.04 17 0.03 
140 0.04 241 0.00   212 0.09 36 0.09 
226 0.05 242 0.03   218 0.05 53 0.07 
232 0.04 248 0.00     68 0.09 
316 0.00 315 0.09     98 0.08 
358 0.07 333 0.07     106 0.04 
368 0.05       111 0.08 
467 0.01         
687 0.07         
699 0.07         
737 0.09         
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Table S4 Sequenced IPNV samples. NA=not assigned, Atlantic salmon (Salmo salar), rainbow trout 
(Oncorhynchus mykiss), brown trout (Salmo trutta), turbot (Scophthalmus maximus). 
Sequence 
ID 
Collection 
Year 
Confirmed 
Serotype 
Cell line Host Origin Region 
IPNV006 1982 NA CHSE-214 S. salar UK Scotland, Argyll 
IPNV060 1983 NA CHSE-214 NA NA NA 
IPNV007 1984 NA CHSE-214 O. mykiss UK Scotland, Borders 
IPNV008 1984 NA CHSE-214 O. mykiss  UK Scotland, Borders 
IPNV011 1986 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV061 1986 Sp CHSE-214 S. 
maximus 
NA NA 
IPNV019 1987 NA CHSE-214 O. mykiss UK Scotland, Highlands 
IPNV021 1987 NA CHSE-214 O. mykiss UK Scotland, Strathclyde 
IPNV062 1987 NA CHSE-214 S. salar NA NA 
IPNV063 1987 Ab CHSE-214 S. salar NA NA 
IPNV064 1987 Ab CHSE-214 NA UK Scotland, Highlands 
IPNV065 1987 Ab CHSE-214 NA UK Scotland, Highlands 
IPNV066 1988 Ab CHSE-214 S. salar UK Scotland, Highlands 
IPNV027 1989 NA CHSE-214 O. mykiss UK Scotland, Borders 
IPNV032 1989 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV068 1989 Ab CHSE-214 S. salar UK Scotland, Highlands 
IPNV026 1990 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV069 1992 Ab CHSE-214 S. salar NA NA 
IPNV070 1992 Sp CHSE-214 NA Norway Norway 
IPNV071 1992 Sp TO NA UK Scotland, Argyll 
IPNV072 1992 Sp CHSE-214 NA UK Scotland, Shetland 
IPNV073 1993 Sp CHSE-214 S. salar NA NA 
IPNV075 1993 Sp TO S. salar Norway Norway 
IPNV076 1994 Sp TO S. salar NA NA 
IPNV081 1994 NA CHSE-214 S. salar NA NA 
IPNV082 1996 Sp CHSE-214 S. salar NA NA 
IPNV083 1997 Sp CHSE-214 S. salar NA NA 
IPNV084 1997 Sp CHSE-214 S. salar NA NA 
IPNV087 1997 Sp CHSE-214 S. salar NA NA 
IPNV088 1997 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV090 1998 Sp CHSE-214 S. salar NA NA 
IPNV107 1999 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV111 1999 Sp CHSE-214 S. salar UK Scotland, Shetland 
IPNV001 2000 Sp TO S. salar NA NA 
IPNV003 2002 Sp TO S. salar NA NA 
IPNV009 2003 Sp CHSE-214 S. salar UK Scotland, Argyll 
IPNV010 2003 Sp TO S. salar NA NA 
 4 
IPNV013 2004 Sp TO S. salar UK Scotland, Argyll 
IPNV014 2004 Sp CHSE-214 NA NA NA 
IPNV018 2004 Sp TO NA NA NA 
IPNV024 2005 Sp TO S. salar NA NA 
IPNV030 2006 Sp TO S. salar NA NA 
IPNV031 2006 Sp TO S. trutta UK Scotland, Shetland 
IPNV035 2007 Sp CHSE-214 S. trutta UK Scotland, Shetland 
IPNV039 2008 Sp CHSE-214 S. salar NA NA 
IPNV051 2010 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV052 2011 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV053 2011 NA CHSE-214 S. salar UK Scotland, Strathclyde 
IPNV054 2011 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV055 2012 NA CHSE-214 S. salar UK Scotland, Highlands 
IPNV056 2012 NA CHSE-214 S. salar UK Scotland, Orkney 
IPNV057 2013 NA CHSE-214 S. salar UK Scotland, Shetland 
IPNV047 2014 Sp CHSE-214 NA NA NA 
IPNV048 2014 Sp CHSE-214 NA NA NA 
IPNV049 2014 Sp CHSE-214 NA NA NA 
IPNV050 2014 Sp CHSE-214 NA NA NA 
IPNV058 2014 NA CHSE-214 S. salar UK Scotland, Outer 
Hebrides 
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Table S5 Reference strains used for phylogenetic analysis of segment A; NA means not assigned. 
 
Strain 
 
GenBank 
 
Geographical 
Origin 
 
 
Host 
 
Reference 
Ca3 AF342734 Canada Salvelinus alpinus [18] 
Connecticut1 JF440810 USA Salmo spec. [94] 
Ca2 AF342733 Canada Oncorhynchus spec [18] 
TABV2013 KP268663.1 Australia Oncorhynchus mykiss [95] 
TABV1998 NC_028252.1 Australia Gadus spec [95] 
1146 AJ489222.1 Spain Trout (not further 
specified) 
[96] 
Sp KF279643 Iran Trout (not further 
specified) 
[97] 
Gre NA Turkey Oncorhynchus mykiss unpublished 
SDF4 NA Turkey Oncorhynchus mykiss unpublished 
1054 NA Turkey Oncorhynchus mykiss unpublished 
Sp AF342728 Denmark Trout (not further 
specified) 
[18] 
Ireland HQ457197.1 Ireland Salmon salar [36] 
DPL AY026485.1 Thailand Snakehead fish 
(Channidae) 
[18] 
Fr21 AY026483.1 France Trout (not further 
specified) 
[18] 
OV2 AY026484.1 England, UK Oyster (Ostreidae) [18] 
N1 D00701 Norway Salmon salar [98] 
Chile HQ457169 Chile Salmon (not further 
specified) 
[36] 
Norway HQ457199 Norway Salmon salar [36] 
Sp vir. AY374435.1 Norway Salmon salar / 
Oncorhynchus mykiss 
[19] 
Ab AF342729 Denmark Trout (not further 
specified) 
[18] 
2284 AJ489223 Spain Trout (not further 
specified) 
[96] 
Ab L40580.1 Denmark NA [99] 
CVHB1 AY026489.1 Taiwan Clam (not further 
specified) 
[18] 
S AY026487 Taiwan Eel (Anguilliformes) [18] 
V AY026486.1 Japan Eel (not further 
specified) 
[18] 
PV AY026488.1 Taiwan Perch (Perca) [18] 
Ca1 AF342732 Canada Trout (not further 
specified) 
[18] 
ASV AY026490.1 Canada Salmon (not further 
specified) 
[18] 
Te2 AF342731 England, UK Tellina (Tellina) [18] 
AY98 AY283785.1 Japan Ayu (Plecoglossus) [24] 
YTAV_Y6 AY283781 Japan Yellowtail (Seriola) [24] 
GC1 AY064396.1 Korea Rockfish (not further 
specified) 
unpublished 
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Ja AF342735.1 Canada Trout (not further 
specified) 
[18] 
Reno AY026345 USA Trout (not further 
specified) 
[18] 
Ja2310 AJ489225 Spain Salmon (not further 
specified) 
[96] 
HL1 D26526.1 Korea NA [100] 
Ja NC_001915.1 Canada Trout (not further 
specified) 
[13] 
VR299 AF343572 USA Trout (not further 
specified) 
[18] 
93 AY026346.1 USA Trout (not further 
specified) 
[18] 
11 AY026347.1 USA Trout (not further 
specified) 
[18] 
Mexico JX174178 Mexico Trout (not further 
specified) 
unpublished 
114 AY026348 USA Trout (not further 
specified) 
[18] 
91 AF343570 USA Trout (not further 
specified) 
[18] 
Buhl AF343573 USA Trout (not further 
specified) 
[18] 
DryMills AF343571.1 USA Trout (not further 
specified) 
[18] 
WB AF342727 USA Trout (not further 
specified) 
[18] 
VTAB NC_030242.1 Australia Oncorhynchus mykiss [95] 
He AF342730 Germany Esox lucius [18] 
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Table S6 Reference strains used for phylogenetic analysis of segment B; NA means not assigned. 
 
Strain 
 
GenBank 
 
Geographical 
Origin 
 
 
Host 
 
Reference 
Mexico EU665685.1 Mexico Trout (Oncorhynchus) unpublished 
HL1 D26527.1 Korea NA [101] 
2310 AJ489241 Spain Salmon (Salmo) [96] 
Ja Duncan NC_001916 Canada Trout [13] 
WB AF078669.1 USA NA [102] 
YTAV-06 AB281674 Japan Yellowtail (Seriola) [103] 
POBV EU161286.1 China Japanese Flounder 
(Paralychthys 
olivaceus) 
[104] 
YTAV-NC1 AY129666 Korea Japanese Flounder 
(not further specified) 
[105] 
Y-6 AY129662 Japan Yellowtail (not further 
specified) 
[105] 
AY-98 AY123970 Japan Ayu (Plecoglossus) unpublished 
VTAB NC_030244.1 Australia Rainbow Trout  [95] 
He JF734351.1 Spain Pike (Esox Lucius) [106] 
Ca2 JF734354 Canada Trout (not further 
specified) 
[106] 
Ca3 JF734355 Canada Trout (not further 
specified) 
[106] 
Ca1 JF734353 Canada Trout (not further 
specified) 
[106] 
Ab1 AM114033.1 NA NA [96] 
Ab2 JF734350.1 NA Trout (not further 
specified) 
[106] 
2284 AJ489239.1 Spain Rainbow Trout 
(Oncorhynchus 
mykiss) 
[96] 
Sp1 AJ622823 France Trout [107] 
IRIPNV KC900161.1 Iran Rainbow Trout [97] 
Gre NA Turkey Rainbow Trout unpublished 
SDF4 NA Turkey Rainbow Trout unpublished 
1054 NA Turkey Rainbow Trout unpublished 
Sp3 AM889221 Denmark Trout (not further 
specified) 
[108] 
Sp2 M58757.1 NA NA [109] 
Sp122 AY354524.1 Norway NA [110] 
Chile KU609618 Chile Salmon (not further 
specified) 
[111] 
Sp116 AY354523 Norway NA [110] 
Sp103 AY354522.1 Norway NA [110] 
TABV2013 KP268678.1 Australia Rainbow Trout [95] 
TABV1998 NC_028253.1 Australia Cod (Gadus) [95] 
Te AJ920336 UK Tellina (Tellina tenuis) [112] 
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Table 1 VP2 characteristic variable residue pattern of sequenced IPNV isolates compared to the 5 
virulent reference strain excluding IPNV032. 6 
Cluster Sequence ID Collection 
Year 
Genogroup VP2 Amino acid position 
    217   221   247   252     281     282       319  
1 IPNVV006, 
011, 019, 
063, 064, 
065, 066, 
068, 069 
1982, 1986, 
1987, 1988, 
1989, 1992 
III P T P A T A A  
2 IPNV007, 
008, 021, 
062, 026, 
070, 071, 
073, 075, 
076, 081, 
083, 084, 
107, 001, 
003, 039 
1984, 1987, 
1990, 1992, 
1993, 1994, 
1997, 1999, 
2000, 2002, 
2008 
I, V P T A N T N A  
3 IPNV027 1989 V P T A N T N V  
4 IPNV024, 
031, 057, 
047, 048, 050 
2005, 2006, 
2013, 2014 
V P T A V T N A  
5 IPNV072 1992 V P A A T T N A  
6 IPNV087, 
088, 090, 111 
1997, 1998, 
1999 
V P A A I T N A  
7 IPNV009, 
010, 013, 
018, 030, 
035, 051, 
052, 054, 
055, 056, 
049, 058 
2003, 2004, 
2006, 2007, 
2010, 2011, 
2012, 2014 
V P A A V T N A  
8 IPNV060, 
061, 082 
1983, 1986, 
1996 
I, V A T E N T A A  
9 IPNV014 2004 V P S A V T N A  
10 IPNV053 2011 V T A A V T N A  
11 Santi et al., 
2004 [1] 
2000 V T A T V T N A  
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